TASLY PHARMACEUTICAL GROUP CO L

TASLY PHARMACEUTICAL GROUP CO L — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006
+Revenue	8.2B	8.5B	8.7B	8.6B	8.0B	13.6B	19.0B	18.0B	16.1B	13.9B	13.2B	12.6B	11.1B	9.3B	6.6B	4.7B	4.0B	3.4B	2.8B	2.4B
Revenue Growth %	-3.1%	-2.0%	0.4%	8.6%	-41.4%	-28.5%	5.6%	11.8%	15.4%	5.5%	5.2%	13.2%	18.8%	42.2%	41.2%	16.5%	16.3%	21.8%	16.3%	--
Total Revenue	8.2B	8.5B	8.7B	8.6B	8.0B	13.6B	19.0B	18.0B	16.1B	13.9B	13.2B	12.6B	11.1B	9.3B	6.6B	4.7B	4.0B	3.4B	2.8B	2.4B
Cost Of Revenue	2.7B	2.8B	2.9B	3.1B	2.7B	8.1B	13.1B	11.5B	10.3B	8.9B	8.1B	7.9B	7.0B	6.2B	4.6B	3.1B	2.7B	2.3B	1.9B	1.6B
+Gross Profit	5.5B	5.7B	5.8B	5.5B	5.3B	5.5B	5.9B	6.5B	5.8B	5.1B	5.1B	4.7B	4.1B	3.2B	2.0B	1.6B	1.3B	1.1B	944.0M	850.0M
Gross Margin %	66.9%	67.1%	66.8%	63.9%	66.3%	40.3%	31.3%	36.2%	36.3%	36.5%	38.7%	37.5%	36.5%	34.0%	30.0%	33.7%	32.7%	33.1%	33.5%	35.1%
Total Operating Cost	7.0B	7.3B	7.2B	7.8B	7.0B	12.5B	17.6B	16.2B	14.4B	12.5B	11.5B	10.9B	9.7B	8.3B	5.9B	4.1B	3.6B	3.1B	2.6B	2.2B
Selling Expenses	3.0B	3.0B	3.0B	2.9B	2.9B	2.6B	2.8B	2.8B	2.5B	2.4B	2.0B	1.8B	1.6B	1.3B	786.0M	632.0M	566.0M	496.0M	412.0M	353.0M
Admin Expenses	334.0M	345.0M	342.0M	374.0M	432.0M	596.0M	640.0M	571.0M	507.0M	869.0M	959.0M	810.0M	815.0M	576.0M	390.0M	306.0M	281.0M	230.0M	231.0M	164.0M
Rd Expenses	686.0M	830.0M	917.0M	845.0M	580.0M	689.0M	551.0M	592.0M	506.0M	--	--	--	--	--	--	--	--	--	--	--
Finance Expenses	-23.3M	-25.2M	-19.1M	30.9M	39.4M	273.0M	435.0M	494.0M	318.0M	228.0M	261.0M	291.0M	148.0M	106.0M	65.0M	61.6M	42.1M	70.8M	42.6M	46.4M
+Operating Income	1.4B	1.1B	1.2B	-160.0M	2.7B	1.5B	1.3B	1.9B	1.7B	1.5B	1.7B	1.7B	1.4B	1.0B	742.0M	536.0M	391.0M	317.0M	226.0M	263.0M
Operating Margin %	16.5%	12.7%	14.2%	-1.9%	34.4%	10.8%	7.0%	10.8%	10.8%	10.5%	13.2%	13.6%	12.6%	11.2%	11.3%	11.5%	9.8%	9.2%	8.0%	10.8%
Non Operating Income	6.5M	14.5M	3.1M	2.6M	3.3M	9.7M	2.5M	17.8M	1.2M	38.1M	59.9M	43.3M	34.8M	145.0M	57.3M	25.4M	13.8M	6.9M	14.2M	544,900
Non Operating Expenses	16.2M	21.7M	9.8M	10.2M	12.7M	25.1M	9.9M	6.7M	9.2M	8.5M	11.7M	19.3M	18.3M	114.0M	13.4M	5.4M	5.8M	9.3M	2.4M	922,500
Investment Income	-183.0M	-84.4M	-111.0M	-21.6M	1.8B	221.0M	-102.0M	127.0M	-32.9M	-10.1M	5.6M	-804,300	3.8M	4.9M	82.9M	5.7M	6.6M	178,100	1.9M	3.1M
Fair Value Change Income	194.0M	-129.0M	-172.0M	-1.1B	-79.9M	118.0M	-67.7M	-1.3M	--	--	--	-74,000	55,700	18,300	--	--	--	--	--	--
Asset Disposal Income	8.6M	2.1M	146,300	1.5M	44.2M	1.7M	386,200	-4.1M	-839,800	649,300	--	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	108.0M	232.0M	5.1M	372.0M	267.0M	64.9M	56.1M	132.0M	77.5M	5.1M	52.3M	-16.4M	59.3M	90.4M	23.4M	7.5M	5.8M	1.7M	13.8M	7.9M
Other Income	73.7M	78.3M	82.8M	95.9M	72.8M	80.7M	147.0M	70.9M	69.8M	--	--	--	--	--	--	--	--	--	--	--
Income Before Tax	1.3B	1.1B	1.2B	-168.0M	2.7B	1.5B	1.3B	2.0B	1.7B	1.5B	1.8B	1.7B	1.4B	1.1B	786.0M	556.0M	399.0M	315.0M	237.0M	263.0M
Income Tax	284.0M	210.0M	204.0M	181.0M	316.0M	367.0M	328.0M	364.0M	334.0M	277.0M	272.0M	283.0M	252.0M	186.0M	146.0M	96.2M	75.5M	64.2M	63.2M	45.2M
+Net Income	1.1B	859.0M	1.0B	-348.0M	2.4B	1.1B	1.0B	1.6B	1.4B	1.2B	1.5B	1.4B	1.2B	894.0M	640.0M	459.0M	324.0M	250.0M	174.0M	218.0M
Net Margin %	12.9%	10.1%	11.7%	-4.0%	30.3%	8.0%	5.3%	8.8%	8.7%	8.7%	11.5%	11.5%	10.5%	9.6%	9.7%	9.9%	8.1%	7.3%	6.2%	9.0%
Net Income Attributable	1.1B	956.0M	1.1B	-264.0M	2.4B	1.1B	1.0B	1.5B	1.4B	1.2B	1.5B	1.4B	1.1B	850.0M	611.0M	450.0M	317.0M	256.0M	186.0M	209.0M
Minority Interest	-43.6M	-96.5M	-54.4M	-84.2M	48.8M	-36.0M	1.7M	46.8M	25.7M	42.8M	45.1M	82.1M	66.1M	43.6M	29.2M	9.1M	6.9M	-5.5M	-11.7M	8.9M
Eps Basic	0.74	0.64	0.72	-0.18	1.57	0.75	0.66	1.02	0.91	1.09	1.38	1.32	1.06	0.82	1.18	0.92	0.65	0.52	0.38	0.46
Eps Diluted	0.74	0.64	0.72	-0.18	1.57	0.75	0.66	1.02	0.91	1.09	1.38	1.32	1.06	0.82	1.18	0.92	0.65	0.52	0.38	0.46

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006
Cash And Equivalents	1.4B	3.0B	4.5B	3.1B	2.3B	2.0B	1.9B	3.1B	1.5B	1.3B	1.1B	1.1B	956.0M	1.0B	1.5B	1.6B	556.0M	404.0M	268.0M	619.0M
Trading Financial Assets	1.4B	525.0M	301.0M	1.1B	1.5B	143.0M	59.4M	--	--	--	--	--	85.0M	26.0M	--	--	--	--	--	--
Accounts Receivable	1.1B	780.0M	688.0M	896.0M	1.3B	1.9B	8.4B	8.3B	6.7B	4.9B	4.6B	3.6B	2.1B	1.3B	808.0M	564.0M	536.0M	519.0M	392.0M	290.0M
Notes Receivable	--	--	--	--	--	--	134.0M	3.0B	3.3B	2.2B	1.8B	1.3B	1.1B	827.0M	727.0M	284.0M	195.0M	144.0M	259.0M	293.0M
Notes And Accounts Receivable	1.1B	780.0M	688.0M	896.0M	1.3B	1.9B	8.6B	11.3B	10.1B	7.1B	6.4B	4.9B	3.1B	2.1B	1.5B	848.0M	731.0M	664.0M	652.0M	583.0M
Prepayments	57.8M	62.0M	65.6M	78.1M	62.3M	97.6M	558.0M	510.0M	371.0M	303.0M	202.0M	140.0M	172.0M	197.0M	119.0M	105.0M	89.3M	88.9M	80.7M	82.4M
Inventory	1.4B	1.7B	1.7B	1.5B	1.5B	1.4B	2.5B	2.4B	2.2B	2.0B	1.8B	1.5B	1.3B	1.1B	745.0M	561.0M	388.0M	313.0M	244.0M	200.0M
Total Current Assets	8.2B	7.3B	8.7B	9.3B	9.2B	9.2B	16.5B	17.8B	15.0B	11.2B	9.9B	7.8B	5.9B	4.6B	4.0B	3.2B	1.8B	1.5B	1.3B	1.5B
Long Term Equity Investment	1.1B	1.3B	1.4B	1.0B	484.0M	922.0M	630.0M	766.0M	845.0M	551.0M	523.0M	401.0M	410.0M	391.0M	393.0M	469.0M	448.0M	172.0M	172.0M	138.0M
Fixed Assets	3.1B	3.2B	3.4B	3.6B	3.7B	3.5B	3.4B	3.4B	3.5B	3.5B	2.8B	2.8B	2.2B	1.9B	1.6B	1.2B	1.1B	1.1B	1.0B	736.0M
Fixed Assets Total	3.1B	3.2B	3.4B	3.6B	3.7B	3.5B	3.4B	3.4B	3.5B	3.5B	2.8B	2.8B	2.2B	1.9B	1.6B	1.2B	1.1B	1.1B	1.0B	736.0M
Construction In Progress	322.0M	222.0M	154.0M	103.0M	168.0M	401.0M	614.0M	520.0M	511.0M	416.0M	858.0M	730.0M	882.0M	496.0M	213.0M	255.0M	227.0M	223.0M	328.0M	417.0M
Construction In Progress Total	322.0M	222.0M	154.0M	103.0M	168.0M	401.0M	614.0M	520.0M	511.0M	416.0M	858.0M	730.0M	882.0M	496.0M	213.0M	255.0M	227.0M	223.0M	329.0M	418.0M
Intangible Assets	794.0M	604.0M	574.0M	459.0M	475.0M	361.0M	409.0M	410.0M	495.0M	516.0M	489.0M	410.0M	378.0M	338.0M	278.0M	172.0M	173.0M	195.0M	210.0M	201.0M
Long Term Deferred Expenses	22.6M	20.7M	23.2M	28.7M	42.3M	127.0M	179.0M	184.0M	179.0M	189.0M	208.0M	182.0M	126.0M	35.7M	24.9M	28.0M	15.3M	8.7M	2.4M	48.9M
Total Non Current Assets	7.1B	7.7B	8.0B	7.2B	7.3B	7.3B	7.5B	7.4B	6.5B	6.0B	5.5B	5.1B	4.5B	3.5B	2.6B	2.3B	2.2B	1.9B	1.9B	1.8B
Total Assets	15.3B	15.0B	16.7B	16.5B	16.5B	16.5B	24.0B	25.2B	21.5B	17.1B	15.4B	12.9B	10.4B	8.1B	6.6B	5.5B	4.0B	3.4B	3.2B	3.3B
Short Term Borrowings	1.1B	700.0M	723.0M	184.0M	178.0M	637.0M	2.6B	3.8B	6.9B	2.4B	3.0B	3.4B	1.8B	423.0M	948.0M	802.0M	802.0M	621.0M	317.0M	273.0M
Accounts Payable	330.0M	419.0M	444.0M	594.0M	531.0M	480.0M	2.1B	2.1B	2.1B	1.9B	1.4B	1.3B	888.0M	711.0M	451.0M	193.0M	157.0M	178.0M	183.0M	183.0M
Advance Receipts	2.5M	66.1M	66.4M	64.1M	66.1M	67.7M	132.0M	76.5M	39.6M	26.3M	19.1M	38.9M	87.5M	89.3M	95.0M	63.5M	11.3M	17.4M	22.2M	21.2M
Contract Liabilities	47.4M	67.5M	89.0M	92.0M	66.0M	26.8M	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	2.3B	2.4B	2.4B	2.1B	1.9B	2.8B	8.7B	8.5B	11.3B	8.2B	6.6B	6.8B	5.1B	3.0B	2.7B	1.8B	1.6B	1.2B	939.0M	1.3B
Long Term Borrowings	217.0M	254.0M	1.4B	1.4B	1.0B	1.0B	927.0M	1.8B	892.0M	--	--	14.7M	72.0M	103.0M	63.0M	225.0M	225.0M	100.0M	195.0M	227.0M
Total Non Current Liabilities	484.0M	515.0M	1.7B	1.7B	1.4B	1.3B	3.5B	5.4B	1.2B	761.0M	1.1B	1.1B	1.1B	679.0M	120.0M	248.0M	243.0M	119.0M	214.0M	248.0M
Total Liabilities	2.8B	2.9B	4.0B	3.8B	3.2B	4.1B	12.2B	14.0B	12.6B	8.9B	7.7B	7.9B	6.2B	3.6B	2.9B	2.0B	1.9B	1.4B	1.2B	1.5B
Paid In Capital	1.5B	1.5B	1.5B	1.5B	1.5B	1.5B	1.5B	1.5B	1.1B	1.1B	1.1B	1.0B	1.0B	516.0M	516.0M	516.0M	488.0M	488.0M	488.0M	285.0M
Capital Reserve	482.0M	459.0M	958.0M	1.5B	1.5B	2.3B	2.0B	1.9B	1.5B	1.5B	1.8B	244.0M	280.0M	1.6B	1.6B	1.6B	564.0M	564.0M	657.0M	572.0M
Surplus Reserve	1.7B	1.7B	1.6B	1.5B	1.4B	1.3B	1.2B	1.1B	939.0M	825.0M	733.0M	636.0M	523.0M	429.0M	324.0M	265.0M	221.0M	188.0M	165.0M	134.0M
Retained Earnings	8.6B	8.2B	8.3B	7.8B	8.8B	7.1B	6.6B	6.2B	5.2B	4.5B	3.9B	2.9B	2.0B	1.7B	1.2B	971.0M	760.0M	672.0M	586.0M	461.0M
Minority Equity	143.0M	208.0M	322.0M	265.0M	333.0M	412.0M	732.0M	675.0M	320.0M	243.0M	237.0M	231.0M	311.0M	253.0M	172.0M	118.0M	138.0M	181.0M	183.0M	294.0M
Equity Attributable	12.4B	11.9B	12.4B	12.4B	13.0B	12.0B	11.1B	10.5B	8.7B	8.0B	7.5B	4.8B	3.9B	4.2B	3.6B	3.3B	2.0B	1.9B	1.9B	1.5B
Total Equity	12.5B	12.1B	12.7B	12.7B	13.3B	12.4B	11.9B	11.2B	9.0B	8.2B	7.7B	5.1B	4.2B	4.5B	3.8B	3.4B	2.2B	2.1B	2.1B	1.7B

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006
Cash From Sales	8.2B	9.3B	10.4B	9.6B	10.0B	14.3B	21.4B	20.1B	15.8B	15.8B	14.0B	12.9B	11.8B	10.3B	7.1B	5.3B	4.6B	3.9B	3.2B	2.7B
Tax Refunds Received	1.4M	2.0M	17.6M	30.4M	--	1.2M	--	--	420,200	1.2M	--	101,700	--	--	--	--	15,500	--	--	756,500
Total Operating Cash Inflow	8.4B	9.4B	10.6B	10.0B	10.2B	14.8B	22.0B	20.8B	16.5B	16.2B	14.3B	13.1B	12.0B	10.5B	7.3B	5.4B	4.6B	4.0B	3.3B	2.7B
Cash Paid For Goods	1.7B	1.9B	2.2B	2.0B	2.0B	7.5B	14.3B	12.8B	11.3B	9.6B	9.0B	8.1B	7.9B	6.9B	5.2B	3.5B	2.9B	2.6B	2.1B	1.7B
Cash Paid To Employees	1.9B	1.9B	2.0B	1.9B	1.9B	1.8B	1.9B	1.8B	1.5B	1.5B	1.4B	1.1B	914.0M	548.0M	371.0M	285.0M	259.0M	235.0M	162.0M	143.0M
Taxes Paid	1.1B	995.0M	1.1B	1.1B	1.0B	1.1B	1.3B	1.7B	1.5B	1.3B	1.3B	1.2B	1.2B	847.0M	581.0M	433.0M	333.0M	367.0M	284.0M	236.0M
Total Operating Cash Outflow	7.0B	7.4B	8.0B	7.7B	7.4B	13.0B	20.3B	19.3B	17.3B	15.1B	14.0B	12.5B	11.7B	10.1B	7.2B	5.0B	4.2B	3.7B	3.0B	2.5B
Operating Cash Flow	1.4B	2.0B	2.6B	2.3B	2.8B	1.8B	1.7B	1.5B	-796.0M	1.2B	340.0M	617.0M	345.0M	452.0M	135.0M	395.0M	400.0M	260.0M	223.0M	141.0M
Total Investing Cash Inflow	6.3B	7.6B	1.8B	3.0B	2.2B	6.1B	6.3B	979.0M	394.0M	363.0M	253.0M	244.0M	135.0M	222.0M	178.0M	33.7M	28.8M	30.1M	68.1M	136.0M
Total Investing Cash Outflow	6.7B	8.6B	3.9B	4.3B	2.2B	5.3B	6.8B	1.6B	1.8B	1.0B	1.2B	811.0M	1.1B	648.0M	497.0M	198.0M	407.0M	210.0M	324.0M	278.0M
Investing Cash Flow	-446.0M	-941.0M	-2.1B	-1.3B	-42.8M	866.0M	-492.0M	-642.0M	-1.4B	-654.0M	-911.0M	-566.0M	-922.0M	-425.0M	-319.0M	-164.0M	-378.0M	-179.0M	-256.0M	-142.0M
Cash From Borrowings	884.0M	1.5B	1.8B	2.7B	1.4B	4.9B	4.3B	11.1B	8.8B	3.8B	6.0B	4.1B	2.8B	1.0B	1.7B	1.5B	1.6B	1.5B	636.0M	682.0M
Dividends And Interest Paid	636.0M	1.1B	563.0M	554.0M	641.0M	800.0M	904.0M	866.0M	934.0M	639.0M	668.0M	704.0M	296.0M	446.0M	369.0M	248.0M	247.0M	207.0M	127.0M	121.0M
Debt Repayments	1.5B	2.5B	1.3B	2.2B	2.6B	6.3B	5.8B	9.8B	5.5B	5.9B	6.5B	2.8B	2.2B	2.2B	1.5B	1.5B	1.3B	1.5B	1.1B	839.0M
Total Financing Cash Inflow	2.4B	3.2B	2.1B	2.8B	1.5B	5.0B	4.4B	11.8B	9.0B	6.8B	8.3B	5.0B	4.0B	2.2B	2.2B	2.7B	1.9B	1.7B	1.0B	1.2B
Total Financing Cash Outflow	2.7B	5.7B	3.3B	3.1B	4.0B	7.3B	6.8B	11.0B	6.6B	7.0B	8.0B	4.9B	3.5B	2.8B	2.2B	2.0B	1.7B	1.7B	1.3B	1.2B
Financing Cash Flow	-370.0M	-2.5B	-1.2B	-237.0M	-2.5B	-2.3B	-2.4B	828.0M	2.4B	-232.0M	286.0M	71.1M	466.0M	-532.0M	-29.9M	781.0M	108.0M	5.3M	-231.0M	-23.3M
Net Change In Cash	598.0M	-1.4B	-731.0M	807.0M	277.0M	334.0M	-1.2B	1.7B	220.0M	267.0M	-286.0M	121.0M	-112.0M	-506.0M	-214.0M	1.0B	130.0M	85.8M	-264.0M	-24.7M
Ending Cash Balance	1.4B	817.0M	2.2B	2.9B	2.1B	1.8B	1.5B	2.7B	1.0B	790.0M	522.0M	808.0M	687.0M	786.0M	1.3B	1.5B	462.0M	331.0M	246.0M	507.0M
Capex	381.0M	565.0M	669.0M	404.0M	572.0M	409.0M	731.0M	780.0M	512.0M	525.0M	738.0M	755.0M	810.0M	555.0M	423.0M	166.0M	117.0M	115.0M	205.0M	255.0M